pmid,title,journal,year,drug,disease
33640469,Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention strategies.,Gastroenterologia y hepatologia,2021,Tofacitinib,Hepatitis A
